Fundraising FoxForesite Capital — 2015 Investments
8 investments dated 2015 · listed companies and verified rows first · show all
Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration.
AI & Machine LearningBiotechHealthtechLongevityMedical DevicesSan Francisco, US
Arnon Rosenthal(Ph.D.)inTillman Gerngross(Director)
BoardCarl Gordon(Director)Terry McGuire(Director)in
Co-investorsGV (Google Ventures)Mission Bay CapitalMission BiocapitalMRL Ventures FundSV Health InvestorsPolaris Partners
Intellia Therapeutics develops in vivo and ex vivo CRISPR/Cas9 gene editing therapies aimed at treating the root causes of severe genetic diseases, with lead candidates for hereditary angioedema and ATTR amyloidosis.
BiotechDeep TechHealthtechCambridge, US
Nessan Bermingham(Founder)inJennifer Doudna(Founder)Jose Rivera(Executive Officer)inJohn Leonard(President and Chief Executive Officer)inJames Basta(Executive Vice President, General Counsel and Corporate Secretary)inEdward Dulac(Executive Vice President, Chief Financial Officer)in
Co-investorsage1Atlas VentureAvoro Capital AdvisorsEcoR1 CapitalOrbiMedRidgeback Capital+1 more
PBM Capital is an investment firm that provides funding and operational support to scientists and entrepreneurs, helping them bring products to market and grow their businesses.
BiotechHealthtechBannockburn, US
Brian Kaspar(Executive Officer, Director)James L'Italien(Executive Officer)Andrew F. Knudten(Executive Officer)Sukumar Nagendran(Executive Officer)Thomas Dee(Executive Officer)Sean Nolan(Executive Officer, Director)
Co-investorsPBM CapitalRA CapitalRoche Venture FundSofinnova VenturesDeerfield Management Company
Corvus Pharmaceuticals is a biopharmaceutical company developing immunology-focused medicines that target cellular components of the immune system, with therapeutic focus on immune diseases and cancer.
BiotechHealthtechBurlingame, US
Richard A. Miller(President & CEO, Co-Founder)inLeiv Lea(Executive Officer)in
BoardElisha (Terry) P. Gould(Director)Peter Moldt(Director)Peter Thompson(Co-Founder)inTerry G. Gould(Director)
Co-investorsAvoro Capital AdvisorsOrbiMedRoche Venture Fund
Gilead Sciences is a biopharmaceutical company headquartered in Foster City, California that discovers, develops, and delivers medicines across virology, oncology, and inflammation.
BiotechHealthtechMedical DevicesNewark, US
Harold Van Wart, Ph. D.(Executive Officer, Director)Pol Boudes(Executive Officer)Charles A. McWherter, Ph. D.(Executive Officer)Sujal Shah(Executive Officer)
BoardCarl Goldfischer, M.D.(Director)Kurt von Emster(Director)in
Co-investorsAvoro Capital AdvisorsBay City CapitalVantagePoint Capital PartnersAbingworth
DNAnexus operates a cloud platform for managing, analyzing, and collaborating on multiomic and clinical data, supporting bioinformatics workflows, AI/ML analytics, and cohort analysis.
AI & Machine LearningBiotechCloud ComputingData & InfrastructureMountain View, US
Andreas Sundquist(Founder)inSerafim Batzoglou(Founder)inRichard Daly(Executive Officer, Director)inGeorge Asimenos, PhD(Chief Product Officer)inArend Sidow(Founder)
BoardMichael Goldberg(Director)
Co-investorsClaremont Creek VenturesGV (Google Ventures)K9 VenturesSaints CapitalUncork CapitalWireframe Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.